104 related articles for article (PubMed ID: 15259382)
1. Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease.
Schmedes A; Nielsen JN; Hey H; Brandslund I
Clin Chem Lab Med; 2004; 42(6):648-53. PubMed ID: 15259382
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
3. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
[TBL] [Abstract][Full Text] [Related]
5. Decreased serum fetuin-A levels and active inflammatory bowel disease.
Ma P; Feng YC
Am J Med Sci; 2014 Jul; 348(1):47-51. PubMed ID: 24487480
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the concordance between biological markers and clinical activity in inflammatory bowel disease].
Miranda García P; Chaparro M; Gisbert JP
Med Clin (Barc); 2015 Jan; 144(1):9-13. PubMed ID: 24530050
[TBL] [Abstract][Full Text] [Related]
7. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
[TBL] [Abstract][Full Text] [Related]
8. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease.
Nielsen OH; Brynskov J; Bendtzen K
Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600
[TBL] [Abstract][Full Text] [Related]
9. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
10. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C
Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980
[TBL] [Abstract][Full Text] [Related]
11. Trace elements and vitamins at diagnosis in pediatric-onset inflammatory bowel disease.
Sikora SK; Spady D; Prosser C; El-Matary W
Clin Pediatr (Phila); 2011 Jun; 50(6):488-92. PubMed ID: 21317196
[TBL] [Abstract][Full Text] [Related]
12. Thiol methyltransferase activity in inflammatory bowel disease.
Roediger WE; Babidge WJ
Gut; 2000 Aug; 47(2):206-10. PubMed ID: 10896911
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
14. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia.
Sabery N; Bass D
Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948
[TBL] [Abstract][Full Text] [Related]
15. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
[TBL] [Abstract][Full Text] [Related]
16. Serum lysozyme in inflammatory bowel disease.
Nugent FW; Mallari R; George H; Ridley N
Gastroenterology; 1976 Jun; 70(6):1014-6. PubMed ID: 1269861
[TBL] [Abstract][Full Text] [Related]
17. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
[TBL] [Abstract][Full Text] [Related]
18. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.
Esteve-Comas M; Ramírez M; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Moreno J; Humbert P; Guilera M
Gut; 1992 Oct; 33(10):1365-9. PubMed ID: 1446861
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin studies in children with inflammatory bowel disease.
Gryboski JD; Buie T
Ann Allergy; 1994 Jun; 72(6):525-7. PubMed ID: 8203795
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of symptoms, laboratory parameters and illness perception in patients with irritable bowel syndrome and inflammatory bowel disease].
Bor R; Balanyi Z; Farkas K; Bálint A; Rutka M; Szűcs M; Milassin Á; Szepes Z; Nagy F; Molnár T
Orv Hetil; 2015 Jun; 156(23):933-8. PubMed ID: 26027601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
